- EN
- EMCDDA >
- Data >
- Statistical archives >
- Statistical bulletin 2007 (archive) >
- Data >
- Treatment demand indicator (TDI) >
- Tables >
- Tables 1-20 >
- Table TDI-3 Part (iii)
Table TDI-3. Distribution by primary drug used of new clients entering treatment, 1993 to 2005 [see all tables in this series...]
Part (iii) Percent of new clients using cannabis
| Country | 1993 | 1994 | 1995 | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Belgium | 8.3 | 13.4 | 14.2 | 27.4 | 27.0 | 25.9 | ||||||||
| Bulgaria | 0.0 | 2.4 | 2.3 | 3.5 | 2.2 | 2.5 | 1.3 | 3.2 | 4.7 | 5.0 | 6.9 | 9.3 | ||
| Czech Republic | 12.1 | 12.0 | 16.3 | 16.3 | 16.7 | 22.0 | 17.6 | 22.7 | 23.6 | 21.6 | 20.4 | |||
| Denmark | 25.0 | 27.0 | 26.0 | 31.0 | 30.0 | 33.0 | 39.3 | 44.1 | 46.6 | 48.3 | ||||
| Germany | 16.7 | 33.3 | 37.7 | 40.0 | 42.6 | 45.0 | 48.0 | 50.7 | 56.4 | 58.0 | ||||
| Ireland | 18.6 | 16.3 | 22.4 | 20.7 | 21.0 | 24.4 | 25.6 | 35.4 | 38.2 | 45.5 | 45.1 | 41.5 | 40.0 | |
| Greece | 5.1 | 8.9 | 11.1 | 18.7 | 10.0 | 10.7 | 6.5 | 10.7 | 11.0 | 11.7 | 10.5 | 10.1 | ||
| Spain | 3.0 | 4.2 | 12.5 | 11.9 | 14.5 | 16.9 | 22.3 | 21.2 | ||||||
| France | 19.6 | 25.6 | 35.9 | 62.6 | ||||||||||
| Italy | 4.9 | 5.1 | 5.9 | 5.8 | 6.9 | 7.6 | 7.9 | 8.0 | 8.2 | 9.1 | 10.3 | 23.8 | 23.8 | |
| Cyprus | 29.6 | 30.5 | 30.0 | 32.3 | 40.2 | |||||||||
| Latvia | 6.9 | 4.4 | 19.7 | 16.9 | ||||||||||
| Lithuania | 0.2 | 0.3 | 0.7 | 0.3 | ||||||||||
| Luxembourg | (1) | 7.0 | 5.0 | 4.0 | 5.0 | 10.0 | 10.0 | 17.0 | 11.0 | 8.0 | 5.4 | 4.9 | ||
| Hungary | (2) | 6.1 | 8.6 | 13.6 | 12.9 | 14.4 | 19.1 | 14.1 | 25.2 | 49.4 | 52.4 | |||
| Malta | (3) | 1.6 | 2.5 | 0.4 | 1.3 | 0.0 | 0.7 | 0.0 | 0.7 | 1.0 | 3.5 | 0.8 | 18.3 | |
| Netherlands | 13.8 | 19.7 | 21.7 | 24.8 | 25.4 | 24.6 | 28.5 | 24.6 | 27.9 | 32.0 | 38.2 | 41.8 | ||
| Austria | (4) | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Poland | (5) | 1.3 | 1.8 | 2.4 | 2.9 | 3.0 | 3.4 | 4.4 | ||||||
| Portugal | 3.4 | 2.5 | 10.6 | 11.7 | 6.8 | |||||||||
| Romania | 1.2 | 2.3 | 4.0 | 3.0 | 4.3 | |||||||||
| Slovenia | 1.3 | 2.4 | 3.9 | 3.8 | 8.4 | 10.8 | 14.3 | 12.7 | 22.7 | 18.3 | 19.6 | |||
| Slovakia | 2,42,4 | 2.4 | 5.9 | 6.6 | 9.0 | 9.7 | 11.8 | 12.2 | 17.9 | 23.8 | 25.2 | 28.8 | ||
| Finland | 31.0 | 32.7 | 36.2 | 41.2 | 39.6 | 38.1 | 42.0 | 31.7 | ||||||
| Sweden | 19.4 | 24.6 | 27.1 | 30.0 | 31.4 | 31.5 | ||||||||
| United Kingdom | (6) | 7.0 | 7.0 | 8.0 | 6.0 | 8.0 | 9.0 | 10.0 | 9.0 | 9.0 | 9.0 | 17.0 | 18.0 | 21.9 |
| Turkey | 29.2 | 28.5 |
Notes:
Sources:
About the EMCDDA
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is the reference point on drugs and drug addiction information in Europe. Inaugurated in Lisbon in 1995, it is one of the EU’s decentralised agencies. Read more >>
Contact us
EMCDDA
Cais do Sodré
1249-289 Lisbon
Portugal
Tel. (351) 211 21 02 00
Fax (351) 218 13 17 11
Quick links
- Home
- Data
Drug-related data at your fingertips
Monitoring and analysing the nature and scale of the drugs phenomenon in Europe is a central part of the EMCDDA's work. The Statistical bulletin is published yearly by the EMCDDA and provides access to the most recent data on the drug situation in Europe. Access data »
- Countries
Drug-related information by country
The countries section makes it easier than ever to find drug-related information and data by country. Each page brings together all of our available products by topic or format for the country in question. Go to the Countries section »
- Topics (A–Z)
New drugs and trends
Health consequences
Prevalence and epidemiology
Drug-related thematic pages
Drugs and society
Science and research
Best practice
- Best practice in prevention
- Best practice in treatment
- Best practice in harm reduction
- Standards and guidelines
- Exchange on Drug Demand Reduction Action (EDDRA)
- Evaluation Instruments Bank (EIB)
Health and social responses
Policy and law
Availability and supply
Drug profiles
Drug profiles are scientifically sound descriptions of drugs.
- Publications
Publications database
Our publications are tailored to the needs of specific audiences and published in a variety of print or web formats. Access the Publications database.
Search
Series/type
Annual report | Drugnet Europe | Drug policy profiles | Drugs in focus | Implementation reports | Insights | Joint publications | Joint reports | Literature reviews | Manuals | Monographs | National reports | Risk assessments | Selected issues | Technical data sheets | Thematic papers
Documents about the EMCDDA
Annual accounts | Brochures | Budget | General report of activities | Work programmes
Annual report: the state of the drugs problem in Europe
The annual report on the state of the drugs problem in Europe presents the EMCDDA's yearly overview of the drug phenomenon. This is an essential reference book for policymakers, specialists and practitioners in the drugs field. It is available for download in PDF in 22 languages or can be accessed as an online publication (English only). - News and events
Media support
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:
Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 21 813 1711
Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 21 813 1711
- About the EMCDDA
Quick links (A-Z)
calls for tender | EMCDDA Director | EMCDDA units | founding regulation | Management Board | national focal points | partners | Scientific Committee | staff list | vacancies
Page last updated: Monday, 12 November 2007